Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Verstraete

Showing results (91-100 of 414) with videos related to

Pageof 42
Sort By:
Circulation|August 1, 1987
New thrombolytic drugs in acute myocardial infarction: theoretical and practical considerationsM Verstraete
Acta Clinica Belgica|January 1, 1976
Oral anticoagulants, dextran or low-dose subcutaneous heparin: which is it to be in the prophylaxis of deep vein thrombosis of operated patients?M Verstraete
Kardiologiia|August 1, 1981
[Problems and prospects for clinical heparin use]M Verstraete
Scandinavian Journal of Haematology. Supplementum|January 1, 1980
Potential and problems with the clinical use of heparinM Verstraete
Recenti Progressi in Medicina|April 1, 1980
[Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy]M Verstraete
Thrombosis and Haemostasis|June 18, 1980
Registry of prospective clinical trials. Fourth ReportM Verstraete
Przeglad Lekarski|January 1, 1977
[Oral anticoagulants, dextran or low-dose subcutaneous heparin: which is it to be in the prophylaxis of deep vein thrombosis of operated patients? (author's transl)]M Verstraete
BMJ (Clinical Research Ed.)|January 11, 1997
Prophylaxis of venous thromboembolismM Verstraete
Acta Cardiologica|January 1, 1991
Unresolved issues in the thrombolytic treatment of myocardial infarctionM Verstraete
Przeglad Lekarski|January 1, 1976
[Thrombolytic therapy in acute and chronic arteriopathy]M Verstraete
Pageof 42

Showing results (91-100 of 414) with videos related to

Sort By:
Pageof 42
Circulation|August 1, 1987
New thrombolytic drugs in acute myocardial infarction: theoretical and practical considerationsM Verstraete
Acta Clinica Belgica|January 1, 1976
Oral anticoagulants, dextran or low-dose subcutaneous heparin: which is it to be in the prophylaxis of deep vein thrombosis of operated patients?M Verstraete
Kardiologiia|August 1, 1981
[Problems and prospects for clinical heparin use]M Verstraete
Scandinavian Journal of Haematology. Supplementum|January 1, 1980
Potential and problems with the clinical use of heparinM Verstraete
Recenti Progressi in Medicina|April 1, 1980
[Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy]M Verstraete
Thrombosis and Haemostasis|June 18, 1980
Registry of prospective clinical trials. Fourth ReportM Verstraete
Przeglad Lekarski|January 1, 1977
[Oral anticoagulants, dextran or low-dose subcutaneous heparin: which is it to be in the prophylaxis of deep vein thrombosis of operated patients? (author's transl)]M Verstraete
BMJ (Clinical Research Ed.)|January 11, 1997
Prophylaxis of venous thromboembolismM Verstraete
Acta Cardiologica|January 1, 1991
Unresolved issues in the thrombolytic treatment of myocardial infarctionM Verstraete
Przeglad Lekarski|January 1, 1976
[Thrombolytic therapy in acute and chronic arteriopathy]M Verstraete
Pageof 42